When the stakes are highest, experience counts for more.

Since 1965, we’ve delivered thoughtful, effective advice backed by research and real-world experience.

  • Rare Disease: 2024 in review

    Projects have spanned a wide range of therapeutic areas and modalities, drawing on our cross-functional expertise in strategy, policy, analytics, and litigation.

    Read the year in review
  • CMA clears acquisition of Teads by Outbrain

    The CMA announced the unconditional clearance of Outbrain’s acquisition of Teads, a deal assisted by a CRA team, following clearances in other jurisdictions.

    Read the engagement
  • 2024 International Arbitration review: Updates and trends

    Work spanned sectors including energy, mining and commodities, life sciences and pharma, technology, and quantum, as well as shareholder disputes and post-M&A arbitrations.

    Learn more here
  • Ann Arbor municipalization study

    The study reveals significant financial and operational challenges associated with the transition to a municipal utility.

    Read more here
  • Rare Disease: 2024 in review

    Projects have spanned a wide range of therapeutic areas and modalities, drawing on our cross-functional expertise in strategy, policy, analytics, and litigation.

    Read the year in review
  • CMA clears acquisition of Teads by Outbrain

    The CMA announced the unconditional clearance of Outbrain’s acquisition of Teads, a deal assisted by a CRA team, following clearances in other jurisdictions.

    Read the engagement
14

See how we can help.

Read our case studies to see the problems we’ve solved and results we’ve delivered.

Explore Our Engagements

Careers at CRA.

We’re always looking for high-performers to join our team of experts.

Start here